DiscGenics, Inc.
Salt Lake City, US · 1 known investors
DiscGenics develops an allogeneic, injectable disc progenitor cell therapy (IDCT/rebonuputemcel) for painful lumbar degenerative disc disease, currently advancing toward a Phase III clinical program. The company works in regenerative spine medicine and cell therapy, and collaborates on tissue-engineered intervertebral disc research.
Founders & leadership
FF
Flagg FlanaganCEO & Chairman
BW
Bob WynalekCOO & Board Member
Investors · 1
Frequently asked questions
- What does DiscGenics, Inc. do?
- DiscGenics develops an allogeneic, injectable disc progenitor cell therapy (IDCT/rebonuputemcel) for painful lumbar degenerative disc disease, currently advancing toward a Phase III clinical program. The company works in regenerative spine medicine and cell therapy, and collaborates on tissue-engineered intervertebral disc research.
- Who are DiscGenics, Inc.'s investors?
- DiscGenics, Inc.'s investors include Medical Incubator Japan K.K..
- Where is DiscGenics, Inc. headquartered?
- DiscGenics, Inc. is headquartered in Salt Lake City, US.